Trial Profile
A multicenter, randomized, double-blind, placebo-controlled, parallel-group study in subjects with irritable bowel syndrome with diarrhea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2017
Price :
$35
*
At a glance
- Drugs Asimadoline (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 06 Aug 2012 Status changed from planning to recruiting.
- 19 Feb 2010 New trial record